Cravath’s New York Office Moves to Two Manhattan West
December 21, 2021
On December 16, 2021, Cravath partner David J. Kappos participated in a webinar hosted by the Center for the Study of the Presidency and Congress. Entitled “Protecting U.S. Intellectual Property & Innovation Leadership,” the session discussed how to avoid policies that could weaken intellectual property protections, disincentivize investment in research and development and reduce the ability of U.S. innovators to support important global technology standards.
Deals & Cases
November 29, 2021
On November 29, 2021, Elsevier, a global leader in research publishing and information analytics and part of RELX, announced that it has acquired Osmosis, a U.S.‑based visual learning education platform for millions of current and future healthcare professionals and their patients. RELX is a global provider of information‑based analytics and decision tools for professional and business customers. Cravath is representing RELX in connection with the transaction.
Deals & Cases
November 29, 2021
Cravath represented Vaxxinity, Inc. in connection with its initial public offering. Vaxxinity is a U.S.‑based global biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Shares began trading on November 11, 2021 on The Nasdaq Global Market.
Deals & Cases
November 15, 2021
On November 15, 2021, CyrusOne Inc. (“CyrusOne”), a premier global data center REIT, KKR, a leading investment firm, and Global Infrastructure Partners, a leading infrastructure investor, announced a definitive agreement pursuant to which KKR and GIP will acquire all outstanding shares of common stock of CyrusOne for $90.50 per share in an all‑cash transaction valued at approximately $15 billion, including the assumption of debt. Upon completion of the transaction, CyrusOne will be a privately held company wholly owned by KKR and GIP and CyrusOne’s common stock will no longer be listed on any public market. Cravath is representing CyrusOne in connection with the transaction.
Deals & Cases
November 15, 2021
On November 15, 2021, Eurazeo, a leading global investment group with considerable private equity, real estate and private debt expertise, announced the signature of an agreement for the acquisition of Scaled Agile, a leading provider of the framework, platform, professional training content and certifications for implementing business agility practices across the enterprise. Eurazeo and its partners will hold a majority stake and invest approximately $300 million. Cravath is representing Eurazeo in connection with the transaction.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.